British drug company GlaxoSmithKline has signed an incentive-laden financing deal worth as much as $1.4 billion to private Redwood City biotechnology company OncoMed Pharmaceuticals, which is developing drugs against cancer stem cells.
OncoMed is trying to make the benefits of cancer treatment more lasting by designing antibodies to help destroy cancer stem cells, a small subset […]
-
Tags
- Cancer News
- Cancer Story
- breast-cancer
- breast_cancer
- american_cancer_society
- cervical_cancer
- cancer_patients
- journal_cancer
- prostate_cancer
- metastatic_breast_cancer
- cancer_treatment
- colorectal_cancer
- john_edwards
- cervical_cancer_vaccine
- cancer_drugs
- breast_cancer_patients
- colon_cancer
- cancer_vaccine
- word_cancer
- cancer_vaccines
- cancer_therapies
- cancer_researchers
- cancer_deaths
- elizabeth_edwards
- cancer
- breast_cancer_cases
- cancer-drug
- breast_cancer_research
- BREAST-CANCER-RISK
- cancer_center
-
Archives
